AUSTIN, DECEMBER 2024: OriGen Biomedical proudly announces that Beth San Segundo, President & CEO, was named a finalist for Phacilitate’s ‘The Women in Advanced Therapies’ Award. This award recognizes an individual or organization that has initiated a call to action to remove barriers and improve and support a diverse working culture across all levels of the Advanced Therapies sector. This award is not limited to women but includes all people who have made a significant positive impact on women’s work lives. There were eight finalists and the shortlist can be viewed here.
Initiatives could include, but are not limited to:
- Ensuring equality of opportunity for all from graduate to board level
- Developing women’s leadership potential, including mentor programs, women’s networks, and return-to-work programs
- Commitment to the inclusion of gender-specific considerations (such as paternity, maternity and adoption initiatives, menopause considerations, and flexible working)
- Improvement in employee diversity over the past 24 months
“Being named a finalist for ‘The Women in Advanced Therapies’ Award is an honor,” said San Segundo. “At OriGen, we believe that fostering an inclusive and equitable environment is essential to driving innovation in advanced therapies. This recognition highlights our ongoing commitment to supporting diversity at every level and ensuring that all individuals have the opportunity to thrive and lead. I am proud to be part of a community that values these principles and works tirelessly to remove barriers for not just women but all those in our industry.”
The winners will be announced during the awards ceremony on Wednesday, January 22, 2025, during Advanced Therapies Week in Dallas, Texas, at the Union Station Wolfgang Puck. The night’s itinerary includes a welcome reception with drinks, dinner, the awards ceremony, and an exciting after-party to cap off the festivities.
ABOUT ORIGEN BIOMEDICAL
OriGen Biomedical, Inc. is a leading producer of cryopreservation and cell culture products. OriGen’s focus is to produce a range of products to support the treatment of cancer, genetic conditions, and other life-threatening diseases. Our products are designed with the patient and user in mind, and we strive to maintain excellent customer service to ensure that patient care is the priority. Quality is the foundation of all product designs at OriGen, and each product is produced with the intention that it will improve patient health. Founded in 1997 and headquartered in Austin, Texas, OriGen is certified annually to ISO 13485 standards and regularly inspected by the FDA, MDSAP, ISO certification organizations, and our customers. To learn more, visit origen.com and follow us on LinkedIn and Twitter.
CONTACT:
Kirsten Krupps – Senior Marketing Manager
OriGen Biomedical, Inc.
k.krupps@origenbio.com
512-474-7278
Download this press release here.
